SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • March 20th, 2015 • Vbi Vaccines Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 20th, 2015 Company Industry JurisdictionTHIS SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of March 19, 2015, is entered into by and among VARIATION BIOTECHNOLOGIES (US), INC., a Delaware corporation (the “Borrower”); VBI Vaccines Inc., a Delaware corporation (“Holdco”); Variation Biotechnologies, Inc., a corporation incorporated under the Canada Business Corporation Company (“Canadian Sub” and together with Holdco, the “Guarantors”); and PCOF 1, LLC (the “Lender”). Terms used herein without definition shall have the meanings ascribed to them in the Credit Agreement defined below.